JPRN-UMIN000033902招募中未知
Effects of empagliflozin vs omarigliptin on beta-cell function in patients with type 2 diabetes: an open-label randomized controlled study - EVOLB study
Yokohama City University Medical Center Department of Endocrinology and Diabetes0 个研究点目标入组 50 人开始时间: 2018年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Use of insulin, DPP-4 inhibitor, GLP-1 receptor agonist, or SGLT-2 inhibitor 2. Type 1 diabetes or secondary forms of diabetes 3. Renal dysfunction (eGFR <35 ml/min/1.73m2) at screening 4. Hepatic dysfunction (AST and/or ALT >3x upper limit of normal) 5. Experiencing cardiovascular event within six month 6. Malignant neoplasm 7. Use of systemic steroid 8. Severe infection or injury 9. Hypersensitivity to empagliflozin or omarigliptin 10. Pregnant or willing to be pregnant during this study 11. Unable to obtain informed consent to this study 12. Unable to maintain compliance during this study 13. Expectation of extremely hyperglycemia during empagliflozin or omarigliptin washout period.
研究者
相似试验
已完成
不适用
Investigation of the effect of empagliflozin on cardiac sympathetic and parasympathetic nerve activity in Japanese patients with type 2 diabetesDiabetes Mellitus (type 2)JPRN-UMIN000029194Shinshu University School of Medicine112
招募中
1 期
Investigating the effect of empagliflozin and melijent in chronic kidney failure patientsDiabetic patients.Type 2 diabetes mellitus with kidney complicationsE11.2IRCT20230607058409N1Shahid Beheshti University of Medical Sciences150
招募中
3 期
The effect of Empagliflozin on outcomes of patients with myocardial infarction undergoing primary PCIIRCT20220809055645N7Rasht University of Medical Sciences54
尚未招募
2 期
Comparing the effect of Empagliflozin, Pioglitazone and their combination, on the course of non-alcoholic fatty liver disease in diabetic patientson-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20230903059343N1Arak University of Medical Sciences120
已完成
4 期
EMPYREAN StudyJPRN-jRCTs031180043Kuwahara Kouichiro113